[go: up one dir, main page]

Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β

Biochem Biophys Res Commun. 2012 Sep 7;425(4):924-30. doi: 10.1016/j.bbrc.2012.08.011. Epub 2012 Aug 11.

Abstract

In this study, we begin to investigate the underlying mechanism of leptin-induced vascular calcification. We found that treatment of cultured bovine aortic smooth muscle cells (BASMCs) with leptin (0.5-4 μg/ml) induced osteoblast differentiation in a dose-dependent manner. Furthermore, we found that leptin significantly increased the mRNA expression of osteopontin and bone sialoprotein, while down-regulating matrix gla protein (MGP) expression in BASMCs. Key factors implicated in osteoblast differentiation, including members of the Wnt signaling pathway, were examined. Exposure to leptin enhanced phosphorylation of GSK-3β on serine-9 thereby inhibiting activity and promoting the nuclear accumulation of β-catenin. Transfection of BASMCs with an adenovirus that expressed constitutively active GSK-3β (Ad-GSK-3β S9A) resulted in a >2-fold increase in GSK-3β activity and a significant decrease in leptin-induced alkaline phosphatase (ALP) activity. In addition, qRT-PCR analysis showed that GSK-3β activation resulted in a significant decrease in the expression of osteopontin and bone sialoprotein, but a marked increase in MGP mRNA expression. When taken together, our results suggest a mechanism by which leptin promotes osteoblast differentiation and vascular calcification in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Animals
  • Calcification, Physiologic / drug effects*
  • Calcium-Binding Proteins / antagonists & inhibitors
  • Cattle
  • Cell Differentiation / drug effects*
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Extracellular Matrix Proteins / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors*
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Integrin-Binding Sialoprotein / biosynthesis
  • Leptin / pharmacology*
  • Matrix Gla Protein
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / enzymology
  • Myocytes, Smooth Muscle / cytology
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / enzymology
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteopontin / biosynthesis
  • beta Catenin / metabolism

Substances

  • Calcium-Binding Proteins
  • Extracellular Matrix Proteins
  • Integrin-Binding Sialoprotein
  • Leptin
  • beta Catenin
  • Osteopontin
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3